Clinical Trial Update: Labetalol Versus Magnesium Sulfate (MgSO4) for the Prevention of Eclampsia Trial [Phase 2, Phase 3]

View source ↗

Summary

The clinical trial comparing labetalol to magnesium sulfate for prevention of eclampsia (NCT00293735) has been withdrawn from Phase 2/3 development.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gestational Hypertension
• Hypertension
• Preeclampsia
• Pregnancy-induced Hypertension
• Superimposed Preeclampsia

Drugs mentioned

• Magnesium sulfate (magnesium sulfate)
• labetalol (labetalol hydrochloride)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Preeclampsia, Pregnancy Induced Hypertension | Phase 2, Phase 3 | Status: WITHDRAWN